drugset / Trial / NCT01454245

A Study to Evaluate the Bioavailability and Food Effect of JNJ-39439335 in Healthy Adult Male Volunteers

NCT01454245

Phase 1 Completed 43 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetics and relative bioavailability of a single dose of 3 capsule formulations of JNJ-39439335 in healthy adult male volunteers. The effect of food on the pharmacokinetics of one of the capsule formulations of JNJ-39439335 will also be evaluated during the study.

Timeline

Start
2011-07
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MAVATREP Small molecule 25 mg Oral

Indications

No indication recorded.